IVEX Raises $5.8M Series A for AV Safety

Amyl Therapeutics

Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating severe peripheral amyloid protein misfolding diseases. By developing novel therapies that recognize and target multiple misfolded proteins, we aim to make a transformative impact on the lives of patients affected by neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, or by systemic amyloidosis. Our approach is shaped by an experienced team with deep drug development experience, and productive collaborations with world-class advisors and partners.

Endo Tools Therapeutics

Endo Tools Therapeutics (ETT) supports physicians with cutting-edge tools, securing patients with state-of-the-art care. ETT is a Belgian company dedicated to the development of innovative medical devices, providing new means of therapeutic interventions for endoscopists.

Relu

Every essential dental appliance, from a routine night guard to a complex crown, relies on the precise work of a dental laboratory. But a deepening shortage of skilled dental technicians is creating a bottleneck that limits how much labs can produce and how fast. Relu, founded in Leuven in 2019, attacks that bottleneck directly. Its Relu® Automate platform uses AI to analyze 3D scans and automatically generate patient-specific designs, such as night guards, surgical guides, and crowns, thereby eliminating the manual CAD steps that slow technicians down. Labs process more cases faster, without compromising quality. The results speak for themselves: Relu now automates designs for more than 80,000 patients each month across 82 countries. The platform is grounded in 33 peer-reviewed publications and carries ISO 13485 certification, FDA 510(k) clearance, and CE marking.